已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016

疾病负担 医疗保健 索引(排版) 医学 全球卫生 环境卫生 区域科学 质量(理念) 业务 公共经济学 人口 经济增长 地理 经济 计算机科学 认识论 万维网 哲学
作者
Nancy Fullman,Jamal A Yearwood,Solomón Mequanente Abay,Cristiana Abbafati,Foad Abd-Allah,Jemal Abdela,Ahmed Abdelalim,Abebe Zegeye,Teshome Abuka Abebo,Victor Aboyans,Haftom Niguse Abraha,Daisy Maria Xavier de Abreu,Laith J. Abu‐Raddad,Akilew Awoke Adane,Rufus Adesoji Adedoyin,Olatunji Adetokunboh,Tara Ballav Adhikari,Ashkan Afshin,Gina Agarwal,Dominic Agius
出处
期刊:The Lancet [Elsevier BV]
卷期号:391 (10136): 2236-2271 被引量:857
标识
DOI:10.1016/s0140-6736(18)30994-2
摘要

A key component of achieving universal health coverage is ensuring that all populations have access to quality health care. Examining where gains have occurred or progress has faltered across and within countries is crucial to guiding decisions and strategies for future improvement. We used the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) to assess personal health-care access and quality with the Healthcare Access and Quality (HAQ) Index for 195 countries and territories, as well as subnational locations in seven countries, from 1990 to 2016. Drawing from established methods and updated estimates from GBD 2016, we used 32 causes from which death should not occur in the presence of effective care to approximate personal health-care access and quality by location and over time. To better isolate potential effects of personal health-care access and quality from underlying risk factor patterns, we risk-standardised cause-specific deaths due to non-cancers by location-year, replacing the local joint exposure of environmental and behavioural risks with the global level of exposure. Supported by the expansion of cancer registry data in GBD 2016, we used mortality-to-incidence ratios for cancers instead of risk-standardised death rates to provide a stronger signal of the effects of personal health care and access on cancer survival. We transformed each cause to a scale of 0-100, with 0 as the first percentile (worst) observed between 1990 and 2016, and 100 as the 99th percentile (best); we set these thresholds at the country level, and then applied them to subnational locations. We applied a principal components analysis to construct the HAQ Index using all scaled cause values, providing an overall score of 0-100 of personal health-care access and quality by location over time. We then compared HAQ Index levels and trends by quintiles on the Socio-demographic Index (SDI), a summary measure of overall development. As derived from the broader GBD study and other data sources, we examined relationships between national HAQ Index scores and potential correlates of performance, such as total health spending per capita. In 2016, HAQ Index performance spanned from a high of 97·1 (95% UI 95·8-98·1) in Iceland, followed by 96·6 (94·9-97·9) in Norway and 96·1 (94·5-97·3) in the Netherlands, to values as low as 18·6 (13·1-24·4) in the Central African Republic, 19·0 (14·3-23·7) in Somalia, and 23·4 (20·2-26·8) in Guinea-Bissau. The pace of progress achieved between 1990 and 2016 varied, with markedly faster improvements occurring between 2000 and 2016 for many countries in sub-Saharan Africa and southeast Asia, whereas several countries in Latin America and elsewhere saw progress stagnate after experiencing considerable advances in the HAQ Index between 1990 and 2000. Striking subnational disparities emerged in personal health-care access and quality, with China and India having particularly large gaps between locations with the highest and lowest scores in 2016. In China, performance ranged from 91·5 (89·1-93·6) in Beijing to 48·0 (43·4-53·2) in Tibet (a 43·5-point difference), while India saw a 30·8-point disparity, from 64·8 (59·6-68·8) in Goa to 34·0 (30·3-38·1) in Assam. Japan recorded the smallest range in subnational HAQ performance in 2016 (a 4·8-point difference), whereas differences between subnational locations with the highest and lowest HAQ Index values were more than two times as high for the USA and three times as high for England. State-level gaps in the HAQ Index in Mexico somewhat narrowed from 1990 to 2016 (from a 20·9-point to 17·0-point difference), whereas in Brazil, disparities slightly increased across states during this time (a 17·2-point to 20·4-point difference). Performance on the HAQ Index showed strong linkages to overall development, with high and high-middle SDI countries generally having higher scores and faster gains for non-communicable diseases. Nonetheless, countries across the development spectrum saw substantial gains in some key health service areas from 2000 to 2016, most notably vaccine-preventable diseases. Overall, national performance on the HAQ Index was positively associated with higher levels of total health spending per capita, as well as health systems inputs, but these relationships were quite heterogeneous, particularly among low-to-middle SDI countries. GBD 2016 provides a more detailed understanding of past success and current challenges in improving personal health-care access and quality worldwide. Despite substantial gains since 2000, many low-SDI and middle-SDI countries face considerable challenges unless heightened policy action and investments focus on advancing access to and quality of health care across key health services, especially non-communicable diseases. Stagnating or minimal improvements experienced by several low-middle to high-middle SDI countries could reflect the complexities of re-orienting both primary and secondary health-care services beyond the more limited foci of the Millennium Development Goals. Alongside initiatives to strengthen public health programmes, the pursuit of universal health coverage hinges upon improving both access and quality worldwide, and thus requires adopting a more comprehensive view-and subsequent provision-of quality health care for all populations. Bill & Melinda Gates Foundation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
半半发布了新的文献求助30
1秒前
2秒前
ATPATP完成签到 ,获得积分10
2秒前
3秒前
平淡金毛应助文静紫烟采纳,获得10
3秒前
5秒前
Sariel完成签到 ,获得积分20
6秒前
xky3371发布了新的文献求助10
7秒前
无法答复发布了新的文献求助10
8秒前
李健的小迷弟应助jella采纳,获得10
9秒前
zhang完成签到 ,获得积分10
9秒前
科研通AI6.2应助gigadrill采纳,获得10
11秒前
林夏发布了新的文献求助10
13秒前
眉姐姐的藕粉桂花糖糕完成签到 ,获得积分10
16秒前
16秒前
霖晚完成签到 ,获得积分10
16秒前
carol完成签到,获得积分10
17秒前
山茶花开完成签到 ,获得积分10
19秒前
英俊的铭应助潇洒不悔采纳,获得10
22秒前
asterzhanger完成签到,获得积分10
24秒前
24秒前
Lu完成签到,获得积分10
24秒前
25秒前
gomm发布了新的文献求助30
26秒前
李子啊完成签到 ,获得积分10
27秒前
黎黎发布了新的文献求助10
29秒前
drcannal发布了新的文献求助10
31秒前
明亮似狮完成签到,获得积分10
32秒前
饼饼完成签到 ,获得积分10
33秒前
淡然之槐完成签到 ,获得积分10
35秒前
南宫初柒完成签到 ,获得积分10
36秒前
拾光完成签到 ,获得积分10
36秒前
郭子啊完成签到 ,获得积分10
39秒前
41秒前
张谋完成签到 ,获得积分10
41秒前
幽默代丝完成签到,获得积分10
42秒前
soilman完成签到,获得积分10
42秒前
43秒前
newbiology完成签到 ,获得积分10
43秒前
43秒前
高分求助中
Markov Chain Monte Carlo 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Common Foundations of American and East Asian Modernisation: From Alexander Hamilton to Junichero Koizumi 5000
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Discerning Saints: Moralization of Intrinsic Motivation and Selective Prosociality at Work 500
Handbuch Trainingswissenschaft – Trainingslehre 500
Additive Manufacturing Design and Applications (ASM Handbook, Volume 24A) 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7584934
求助须知:如何正确求助?哪些是违规求助? 9163473
关于积分的说明 19611112
捐赠科研通 7166594
什么是DOI,文献DOI怎么找? 3266568
关于科研通互助平台的介绍 2431552
邀请新用户注册赠送积分活动 2258232